Adult hippocampal neuroplasticity triggers susceptibility to recurrent depression
Open accessAbstract
Depression is a highly prevalent and recurrent neuropsychiatric disorder associated with alterations in emotional and cognitive domains. Neuroplastic phenomena are increasingly considered central to the etiopathogenesis of and recovery from depression. Nevertheless, a high number of remitted patients experience recurrent episodes of depression, remaining unclear how previous episodes impact on behavior and neuroplasticity and/or whether modulation of neuroplasticity is important to prevent recurrent depression. Through re-exposure to an unpredictable chronic mild stress protocol in rats, we observed the re-appearance of emotional and cognitive deficits. Furthermore, treatment with the antidepressants fluoxetine and imipramine was effective to promote sustained reversion of a depressive-like phenotype; however, their differential impact on adult hippocampal neuroplasticity triggered a distinct response to stress re-exposure: while imipramine re-established hippocampal neurogenesis and neuronal dendritic arborization contributing to resilience to recurrent depressive-like behavior, stress re-exposure in fluoxetine-treated animals resulted in an overproduction of adult-born neurons along with neuronal atrophy of granule neurons, accounting for an increased susceptibility to recurrent behavioral changes typical of depression. Strikingly, cell proliferation arrest compromised the behavior resilience induced by imipramine and buffered the susceptibility to recurrent behavioral changes promoted by fluoxetine. This study shows that previous exposure to a depressive-like episode impacts on the behavioral and neuroanatomical changes triggered by subsequent re-exposure to similar experimental conditions and reveals that the proper control of adult hippocampal neuroplasticity triggered by antidepressants is essential to counteract recurrent depressive-like episodes.
AI snapshot
Written from the paper’s full text.
TL;DR
In rats re-exposed to unpredictable chronic mild stress (uCMS), prior fluoxetine treatment increased susceptibility to recurrent depressive-like behavior and was linked to excessive adult hippocampal neurogenesis plus granule-neuron atrophy, whereas imipramine promoted resilience with normalized neurogenesis and increased dendritic arborization. Arresting cell proliferation with methylazoxymethanol (MAM) blocked imipramine-induced resilience and buffered fluoxetine-induced susceptibility, indicating adult hippocampal neuroplasticity must be finely tuned to prevent recurrence.
Key findings
- After a 4-week stress-free period, uCMS re-exposure decreased sucrose preference in non-treated and fluoxetine-treated animals (F2,14=16.11, P=0.0002; FLX post hoc P=0.0003; IMIP post hoc P>0.1), while imipramine prevented the re-appearance of depressive-like behavior in the forced-swimming test (IMIP post hoc P=0.0112).
- Fluoxetine-treated animals showed a significant increase in BrdU+NeuN+ newborn neurons after re-exposure (FLX post hoc P=0.0319), a significant decrease in Ki-67+Sox-2+ progenitor cells (F2,7=9.642, P=0.0097; FLX post hoc P=0.0106), and significant dendritic atrophy of granule neurons; imipramine-treated animals showed increased dendritic arborization (F2,8=19.70, P=0.0008; IMIP post hoc P=0.0286).
- MAM co-treatment reduced BrdU+NeuN+ cells in both fluoxetine- and imipramine-treated groups (FLX vs FLX+MAM P=0.0303; IMIP vs IMIP+MAM P=0.0153), prevented anhedonic-like signs in fluoxetine-treated animals (FLX+MAM post hoc P>0.1), and led to anhedonic-like behavior in imipramine-treated animals (IMIP+MAM post hoc P<0.001).
- Recurrent uCMS re-exposure also re-emerged anxiety-like behavior and cognitive deficits in non-treated and fluoxetine-treated animals, while imipramine protected most behavioral domains; fluoxetine uniquely prevented deficits in spatial behavioral flexibility (FLX post hoc P=0.0264).
Methods
- Adult male Wistar Han rats (2 months old) were used; n=6–8 for behavioral analysis, with 3–4 per group for gene expression, immunofluorescence, and neuromorphologic studies. Rats underwent 6 weeks of uCMS, with the last 2 weeks including saline, fluoxetine (10 mg kg−1), or imipramine (10 mg kg−1), with subgroups co-administered MAM (7 mg kg−1); BrdU (50 mg kg−1) labeled newborn cells. After 4 weeks without stress, animals were re-exposed to a modified uCMS protocol.
- Behavior was assessed at weeks 6, 10, and 16 using sucrose preference, sweet-drive, novel object recognition, elevated-plus maze, novelty-suppressed feeding, forced-swimming, and Morris water maze tests. Neurogenesis was quantified by BrdU/NeuN/GFAP/Ki-67/Sox-2/DCX immunostaining, dendritic morphology by Golgi-Cox, and neuroplasticity-related gene expression by qRT-PCR. Statistical analysis used GraphPad Prism 6.0 with ANOVA, repeated-measures ANOVA, Bonferroni post hoc tests, and P<0.05.
Limitations
- Stated in the paper: the contribution of other brain regions, such as the nucleus accumbens, to anhedonic resilience cannot be excluded; the distinct effects of fluoxetine and imipramine could be linked to differential impact on neural cell types and/or receptor selectivity, with future studies proposed to block the noradrenergic component of imipramine.
- Evident from the text: only adult male rats were studied, with no female or sex comparison; sample sizes were small (n=6–8 behavioral, 3–4 molecular); MAM itself affected anxiety-like behavior in non-stressed animals (Supplementary Figure 3), a potential confound; and no data points were excluded from analyses.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 47 cited sources checked · 0 supported · 0 flagged
- Findingown data
uCMS re-exposure promoted the re-emergence of an anxious-like phenotype in non-treated animals.
“uCMS re-exposure promoted the re-emergence of an anxious-like phenotype in non-treated (tp3: P<0.001)”
Quote in the paperSubstantial claim - Findingown data
Quantification of progenitor cells revealed no alterations in the number of Ki-67+ proliferating cells among groups.
“quantification of the number of progenitor cells revealed no alterations in the number of Ki-67+ proliferating cells among groups (Figure 3g)”
Quote in the paperNot a substantial claim - Findingown data
Immobility time in the forced-swimming test was significantly increased after repeated uCMS exposure in non-treated animals, suggesting the re-appearance of depressive-like behavior.
“immobility time in the forced-swimming test, a typical surrogate measure of depressive-like behavior, was significantly increased after repeated uCMS exposure (Figure 1e), suggesting the re-appearance of depressive-like behavior in non-treated animals (P<0.01)”
Quote in the paperSubstantial claim - Findingown data
uCMS re-exposure to non-treated animals did not promote the re-appearance of anhedonic-like behavior.
“uCMS re-exposure to non-treated animals did not promote the re-appearance of anhedonic-like behavior (tp3: P>0.1, Figure 1d)”
Quote in the paperSubstantial claim - Findingown data
The reversion of anhedonic behavior by fluoxetine and imipramine was preserved after a 4-week stress-free period.
“This effect was preserved after a 4-week stress-free period (tp2).”
Quote in the paperSubstantial claim
- Findingown data
Recurrent uCMS exposure produced a significant decrease in the number of neuroblasts, revealed by decreased Ki-67+DCX+ cells and decreased gene expression of NEUROD1 and DCX.
“recurrent uCMS exposure produced a significant decrease in the number of neuroblasts, revealed by a decreased number of Ki-67+DCX+ (P=0.0186, Figures 3j and k), and also evidenced by the decreased gene expression of NEUROD1 and DCX (NEUROD1: P=0.0088; DCX: P=0.0481, Figure 3l)”
Quote in the paperSubstantial claim - Findingown data
uCMS exposure significantly affected cognition, decreasing novel object exploration in the novel object recognition test.
“cognition was significantly affected by uCMS exposure, as it decreased novel object exploration in the novel object recognition test (tp1, P=0.0011, Figure 2a)”
Quote in the paperSubstantial claim - Findingown data
Imipramine prevented alterations in the expression of both NCAM and SYN1 after stress re-exposure.
“imipramine prevented alterations in the expression of both NCAM and SYN1 (NCAM: F2,13=4.890, P=0.0261; FLX: post hoc P=0.3926; IMIP: post hoc P=0.0240; SYN1: F2,14=22.64, P<0.001; FLX: post hoc P=0.001; IMIP: post hoc P<0.001, Figures 4d and e)”
Quote in the paperSubstantial claim - Findingown data
Stress re-exposure in non-treated animals did not affect neuronal arborization.
“although stress re-exposure in non-treated animals did not affect neuronal arborization”
Quote in the paperSubstantial claim - Findingown data
Fluoxetine-treated animals showed increased immobility time in the forced-swimming test after repeated uCMS exposure, similar to non-treated animals.
“similarly to those treated with fluoxetine (F2,14=7.078, P=0.0075; FLX: post hoc P>0.1; Figure 1e)”
Quote in the paperSubstantial claim - Findingown data
No statistical differences were observed in hippocampal cell proliferation or newborn cells in imipramine-treated animals compared with nonstressed animals.
“as well as in the imipramine-treated animals, in comparison with nonstressed animals (BrdU+: P=0.1792, F2,6=4.435, P=0.0657; IMIP: post hoc P>0.1, Figure 3a; BrdU+NeuN+: P=0.1584, F2,5=8.381, P=0.0253; IMIP: post hoc P>0.1, Figures 3b and c)”
Quote in the paperSubstantial claim - Findingown data
Fluoxetine treatment tends to revert the decreased expression of NEUROD1 and DCX induced by recurrent stress.
“fluoxetine treatment tends to revert the decreased expression of NEUROD1 and DCX induced by recurrent stress (NEUROD1: F2,6=5.759, P=0.0402; FLX: post hoc P=0.0509; DCX: F2,8=5.170, P=0,0362; FLX: post hoc P=0.0419, Figure 3l)”
Quote in the paperNot a substantial claim - Findingown data
Animals treated with imipramine during the first uCMS exposure showed resilience to anhedonic-like behavior after uCMS re-exposure.
“the same resilience was observed in animals treated with imipramine during the first uCMS exposure.”
Quote in the paperSubstantial claim - Findingown data
Treatment with imipramine prevented the re-appearance of depressive-like behavior after uCMS re-exposure.
“the treatment with imipramine successfully prevented the re-appearance of depressive-like behavior after uCMS re-exposure (IMIP: post hoc P=0.0112, Figure 1e)”
Quote in the paperSubstantial claim - Findingown data
Exposure to uCMS elicited an anhedonic state manifested by decreased sucrose preference.
“exposure to uCMS elicited an anhedonic state manifested by decreased sucrose preference in the sucrose preference test”
Quote in the paperSubstantial claim - Findingown data
uCMS re-exposure did not elicit long-term memory deficits in imipramine-treated animals.
“but not imipramine-treated animals (tp3, P=0.0001; F2,29=1.482, P<0.0001; FLX: post hoc P>0.99; IMIP: post hoc P=0.0001, Figure 2c)”
Quote in the paperSubstantial claim - Findingown data
Imipramine-treated animals presented a robust increase in neuronal dendritic arborization on stress re-exposure.
“imipramine-treated animals, on stress re-exposure presented a robust increase in neuronal dendritic arborization (F2,8=19.70, P=0.0008; FLX: post hoc P=0.0429; IMIP: post hoc P=0.0286, Figures 4a and c)”
Quote in the paperSubstantial claim - Findingown data
Gene expression analysis of neuroplastic-related genes revealed a marked decrease of NCAM and SYN1 expression after stress re-exposure, suggesting deficits in synaptic plasticity.
“gene expression analysis of neuroplastic-related genes revealed a marked decrease of NCAM (P=0.0002) and SYN1 (P=0.0027) expression, suggesting deficits in synaptic plasticity”
Quote in the paperSubstantial claim - Findingown data
Prior treatment with fluoxetine or imipramine blocked the emergence of cognitive deficits on the probe trial.
“Prior treatment with fluoxetine or imipramine blocked the emergence of cognitive deficits on the probe trial (F2,13=9.241, P=0.0032; FLX: post hoc P=0.0032; IMIP: post hoc P=0.0484, Figure 2g).”
Quote in the paperSubstantial claim - Findingown data
uCMS re-exposure promoted the re-emergence of an anxious-like phenotype in fluoxetine-treated animals.
“but also in fluoxetine-treated animals (F2,12=8.786, P=0.0045; FLX: post hoc P>0.1)”
Quote in the paperSubstantial claim - Findingown data
Cell proliferation arrest buffered the susceptibility to recurrent behavioral changes promoted by fluoxetine.
“and buffered the susceptibility to recurrent behavioral changes promoted by fluoxetine.”
Quote in the paperSubstantial claim - Findingown data
Imipramine-treated animals presented corticosterone levels similar to the non-stressed group after uCMS re-exposure.
“imipramine-treated animals presented corticosterone levels similar to the non-stressed group (IMIP: post hoc P=0.0288, Figure 1i)”
Quote in the paperSubstantial claim - Findingown data
No statistical differences were observed in hippocampal cell proliferation or newborn cells in non-treated uCMS re-exposed animals compared with nonstressed animals.
“No statistical differences were observed in the hippocampal cell proliferation or newborn cells in non-treated uCMS re-exposed animals, as well as in the imipramine-treated animals, in comparison with nonstressed animals (BrdU+: P=0.1792, F2,6=4.435, P=0.0657; IMIP: post hoc P>0.1, Figure 3a; BrdU+NeuN+: P=0.1584, F2,5=8.381, P=0.0253; IMIP: post hoc P>0.1, Figures 3b and c)”
Quote in the paperSubstantial claim - Findingown data
Animals pre-treated with fluoxetine presented significant dendritic atrophy after stress re-exposure.
“animals pre-treated with fluoxetine presented significant dendritic atrophy (Figures 4a and c)”
Quote in the paperSubstantial claim - Findingown data
Imipramine promoted an overall increase in dendritic arborization.
“whereas imipramine promoted an overall increase in dendritic arborization (Figure 4b)”
Quote in the paperSubstantial claim - Findingown data
A significant decrease in the number of Ki-67+Sox-2+ progenitor cells was observed in fluoxetine-treated animals.
“a significant decrease in the number of Ki-67+Sox-2+ progenitor cells in fluoxetine-treated animals was observed (F2,7=9.642, P=0.0097; FLX: post hoc P=0.0106, Figures 3h and i)”
Quote in the paperSubstantial claim - Findingown data
uCMS re-exposure induced deficits in the reference memory task in the Morris water maze.
“uCMS re-exposure induced deficits in the reference memory task, particularly evident in the third day of the test (Figure 2e)”
Quote in the paperSubstantial claim - Findingown data
Treatment with fluoxetine and imipramine was effective to promote sustained reversion of a depressive-like phenotype.
“treatment with the antidepressants fluoxetine and imipramine was effective to promote sustained reversion of a depressive-like phenotype”
Quote in the paperSubstantial claim - Findingown data
Plasma corticosterone levels after uCMS re-exposure were elevated in non-treated animals compared with non-stressed animals.
“The analysis of plasma corticosterone levels in blood serum, after uCMS re-exposure, revealed elevated levels in non-treated (P<0.001)”
Quote in the paperNot a substantial claim - Findingown data
The impairment in long-term memory induced by uCMS was significantly reversed by imipramine.
“such impairment in long-term memory was significantly reversed by imipramine (tp1, F2,36=3.566, P=0.0386; FLX: post hoc P=0.6358; IMIP: post hoc P=0.0340, Figure 2a)”
Quote in the paperSubstantial claim - Findingown data
Treatment with fluoxetine conferred susceptibility to anhedonic-like behavior after uCMS re-exposure, denoted by significantly decreased sucrose preference.
“treatment with fluoxetine conferred susceptibility to anhedonic-like behavior as denoted by the significantly decreased sucrose preference (F2,14=16.11, P=0.0002; FLX: post hoc P=0.0003; IMIP: post hoc P>0.1, Figure 1d)”
Quote in the paperSubstantial claim - Findingown data
Spontaneous recovery of anhedonic behavior was achieved in uCMS non-treated animals.
“Spontaneous recovery of anhedonic behavior was also achieved in uCMS non-treated animals (P>0.1, Figure 1c).”
Quote in the paperSubstantial claim - Findingown data
uCMS re-exposure elicited the re-appearance of long-term memory deficits in fluoxetine-treated animals.
“and fluoxetine-treated animals, but not imipramine-treated animals (tp3, P=0.0001; F2,29=1.482, P<0.0001; FLX: post hoc P>0.99; IMIP: post hoc P=0.0001, Figure 2c)”
Quote in the paperSubstantial claim - Findingown data
uCMS re-exposure elicited the re-appearance of long-term memory deficits in non-treated animals.
“uCMS re-exposure elicited the re-appearance of long-term memory deficits by decreasing novel object exploration in non-treated”
Quote in the paperSubstantial claim - Findingown data
The anhedonic state induced by uCMS was reverted by both fluoxetine and imipramine treatment.
“that was reverted by both fluoxetine and imipramine treatment (tp1, P=0.0008; F2,14=15.21, P=0.0003; FLX: post hoc P=0.0003; IMIP: post hoc P=0.0033, Figure 1b)”
Quote in the paperNot a substantial claim - Findingown data
Sholl analysis revealed reduced complexity of granule neurons in fluoxetine-treated animals.
“Sholl analysis revealed a reduced complexity of granule neurons in fluoxetine-treated animals”
Quote in the paperSubstantial claim - Findingown data
Cell proliferation arrest compromised the behavior resilience induced by imipramine.
“cell proliferation arrest compromised the behavior resilience induced by imipramine”
Quote in the paperSubstantial claim - Findingown data
Plasma corticosterone levels after uCMS re-exposure were elevated in fluoxetine-treated animals compared with non-stressed animals.
“and fluoxetine-treated animals (F2,9=26.40, P=0.0002; FLX: post hoc P=0.0040, Figure 1i), when compared with non-stressed animals”
Quote in the paperSubstantial claim - Findingown data
Treatment with fluoxetine induced a significant increase of newborn neurons in the adult DG, identified as BrdU+NeuN+ cells.
“the treatment with fluoxetine tends to increase the number of BrdU+ cells (FLX: post hoc P=0.0795; Figure 3a) and induced a significant increase of newborn neurons in the adult DG, identified as BrdU+NeuN+ cells (FLX: post hoc P=0.0319; Figures 3b and c)”
Quote in the paperSubstantial claim - Findingown data
Following a 4-week stress-free period, no signs of anxiety-like behavior were observed in the novelty-suppressed feeding test in both non-treated and treated animals.
“Following a 4-week stress-free period, no signs of anxiety-like behavior were observed in the novelty-suppressed feeding test in both non-treated and treated animals (tp2, Figure 1g).”
Quote in the paperNot a substantial claim - Findingown data
Four weeks after cessation of the uCMS protocol, no cognitive deficits were observed in any experimental group.
“Four weeks after cessation of the uCMS protocol, no cognitive deficits were observed in any experimental group (tp2, Figure 2b).”
Quote in the paperNot a substantial claim - Findingown data
Imipramine-treated animals did not display signs of anxiety-like behavior after uCMS re-exposure.
“imipramine-treated animals did not display signs of anxiety-like behavior after uCMS re-exposure (IMIP: post hoc P=0.0048, Figure 1h)”
Quote in the paperSubstantial claim - Findingown data
Re-exposure to uCMS in rats produced the re-appearance of emotional and cognitive deficits.
“Through re-exposure to an unpredictable chronic mild stress protocol in rats, we observed the re-appearance of emotional and cognitive deficits.”
Quote in the paperSubstantial claim - Findingown data
Fluoxetine treatment prevented changes in the expression of SYN1 after stress re-exposure.
“fluoxetine treatment was able to prevent changes in the expression of SYN1”
Quote in the paperSubstantial claim - Findingown data
Treatment with fluoxetine or imipramine prevented the cognitive deficits in the reference memory task induced by uCMS re-exposure.
“In this specific task, treatment with fluoxetine or imipramine prevented such cognitive deficits (Figure 2e).”
Quote in the paperSubstantial claim - Findingcitation
Fluoxetine treatment and further stress re-exposure also induced dendritic atrophy of the DG granule neurons, similar to the immediate effects induced by uCMS protocol in non-treated animals.
“Besides boosting adult neurogenesis, fluoxetine treatment and further stress re-exposure also induced dendritic atrophy of the DG granule neurons, similar to the immediate effects induced by uCMS protocol in non-treated animals.9”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [9] Bessa JM, Ferreira D, Melo I, Marques F, Cerqueira JJ, Palha JA et al. The mood-improving actions of antidepressants do not depend on neurogenesis but are associated with neuronal remodeling. Mol Psychiatry 2009; 14: 764–773, 739. source
Not checked in the free run.
- Findingown data
Co-administration of MAM and fluoxetine prevented the re-emergence of anhedonic- and anxiety-like behavior triggered by uCMS re-exposure.
“Interestingly, co-administration of MAM and fluoxetine prevented the re-emergence of anhedonic- and anxiety-like behavior triggered by uCMS re-exposure.”
Quote in the paperSubstantial claim- Rests on an assumption: The uCMS protocol in animals is a valid model of recurrent depression in humans.
- Findingnone given
uCMS induces persistent morphological, namely synaptic, and behavioral scars that are observed even 4 weeks post stress exposure.
“However, uCMS induces persistent morphological, namely synaptic, and behavioral scars that are observed even 4 weeks post stress exposure.”
Quote in the paperSubstantial claim- Rests on an assumption: The uCMS protocol in animals is a valid model of recurrent depression in humans.
- Findingown data
MAM treatment compromised the therapeutic protection conferred by imipramine for anxiety-like behavior, leading to an anxious-like state.
“while it compromised the therapeutic protection conferred by imipramine for this behavioral dimension, leading to an anxious-like state (IMIP: post hoc P=0.017; IMIP+MAM: post hoc P>0.1, Figure 5d).”
Quote in the paperSubstantial claim - Findingown data
Cell proliferation arrest led to the appearance of anhedonic-like behavior in animals co-treated with imipramine.
“Remarkably, cell proliferation arrest led to the appearance of anhedonic-like behavior in animals co-treated with imipramine (IMIP+MAM: post hoc P<0.001, Figure 5c).”
Quote in the paperSubstantial claim - Findingreasoning
Suppression of cell genesis by co-administration of MAM prevented the resilience to behavioral alterations on treatment with imipramine.
“In fact, the maintenance of adult neurogenesis at certain levels was required to prevent behavior deficits induced by recurrent stress, as the suppression of cell genesis by co-administration of MAM prevented the resilience to behavioral alterations on treatment with imipramine.”
Quote in the paperSubstantial claim - Findingown data
MAM treatment prevented anxiety-like signs promoted by fluoxetine.
“In addition, the MAM treatment prevented anxiety-like signs promoted by fluoxetine (F2,22=15.70, P<0.001; FLX: post hoc P>0.1; FLX+MAM: post hoc P=0.0134, Figure 5d)”
Quote in the paperSubstantial claim - Findingown data
Co-treatment with MAM in imipramine-treated animals elicited significantly lower levels of neurogenesis, similar to those observed in stressed non-treated animals.
“Concerning imipramine, co-treatment with MAM elicited significantly lower levels of neurogenesis, similar to those observed in stressed non-treated animals (IMIP vs IMIP+MAM: P=0.0153, Figure 5b).”
Quote in the paperSubstantial claim - Findingown data
A recurrent stress exposure promotes the re-appearance of anxiety and cognitive deficits.
“This study shows that a recurrent stress exposure promotes the re-appearance of anxiety and cognitive deficits.”
Quote in the paperSubstantial claim- Rests on an assumption: The uCMS protocol in animals is a valid model of recurrent depression in humans.
- Findingown data
Cell proliferation blockage by MAM had no significant effect on the cognitive performance of animals treated either with fluoxetine or imipramine.
“Despite the importance of cell genesis modulation for the AD effects on emotional behaviors, results of the Morris water maze revealed that cell proliferation blockage by MAM had no significant effect on the cognitive performance of animals treated either with fluoxetine or imipramine (Figures 5e and f).”
Quote in the paperNot a substantial claim - Findingown data
The impact of an initial uCMS, followed by a recovery period, increases animals' ability to cope with uCMS re-exposure in particular behavioral traits, such as anhedonia.
“Strikingly, our results also show that the impact of an initial uCMS, followed by a recovery period, increases animals' ability to cope with uCMS re-exposure in particular behavioral traits, such as anhedonia.”
Quote in the paperSubstantial claim- Rests on an assumption: The uCMS protocol in animals is a valid model of recurrent depression in humans.
- Findingown data
In consequence of the higher recruitment of cells for differentiation caused by fluoxetine treatment, there was a strong depletion in the number of progenitor cells and neuroblasts in the hippocampal DG.
“Noticeably, in consequence of the higher recruitment of cells for differentiation caused by fluoxetine treatment, we also observed, as expected, a strong depletion in the number of progenitor cells and neuroblasts in the hippocampal DG.”
Quote in the paperSubstantial claim - Findingreasoning
Fluoxetine treatment was not able to restore the levels of neuronal differentiation.
“Despite the attempt to potentiate the neurogenic process, denoted by the increased expression of neuronal maturation-related markers, fluoxetine treatment was not able to restore the levels of neuronal differentiation possibly due to the depletion of neural progenitors.”
Quote in the paperSubstantial claim - Findingown data
Treatment with imipramine conferred protection to uCMS re-exposure in the majority of behavioral domains assessed, including cognitive and anxiety-like behavior.
“Contrastingly, treatment with imipramine conferred protection to uCMS re-exposure in the majority of behavioral domains assessed, including cognitive, and anxiety-like behavior.”
Quote in the paperSubstantial claim- Rests on an assumption: The uCMS protocol in animals is a valid model of recurrent depression in humans.
- Rests on an assumption: The effects of fluoxetine and imipramine in the uCMS animal model predict their effects in human recurrent depression.
- Findingown data
Neurogenesis arrestment prevented anhedonic-like signs observed in animals co-treated with fluoxetine during the first uCMS exposure.
“Further assessment of anhedonic-like behavior by the sweet-drive test after uCMS re-exposure revealed that neurogenesis arrestment prevented anhedonic-like signs observed in animals co-treated with fluoxetine during the first uCMS exposure (FLX+MAM: post hoc P>0.1, Figure 5c).”
Quote in the paperSubstantial claim - Findingown data
Fluoxetine-treated animals were resilient to a specific cognitive task, namely spatial reversal learning, that was compromised in non-treated animals.
“Strikingly, fluoxetine-treated animals where resilient to a specific cognitive task, namely spatial reversal learning, that was compromised in non-treated animals.”
Quote in the paperNot a substantial claim - Premisecitation
Abrogation of hippocampal neurogenesis in adolescence blocks susceptibility to chronic social defeat in adulthood.
“abrogation of hippocampal neurogenesis in adolescence blocked susceptibility to chronic social defeat in adulthood.8”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [8] Kirshenbaum GS, Lieberman SR, Briner TJ, Leonardo ED, Dranovsky A . Adolescent but not adult-born neurons are critical for susceptibility to chronic social defeat. Front Behav Neurosci 2014; 8: 289. source
Not checked in the free run.
- Interpretationown data
Previous exposure to a depressive-like episode impacts the behavioral and neuroanatomical changes triggered by subsequent re-exposure to similar experimental conditions.
“This study shows that previous exposure to a depressive-like episode impacts on the behavioral and neuroanatomical changes triggered by subsequent re-exposure to similar experimental conditions”
Quote in the paperSubstantial claim- Rests on an assumption: The unpredictable chronic mild stress (uCMS) protocol in rats models recurrent depression in humans.
- Interpretationown data
Pre-treatment with fluoxetine or imipramine confers a different profile of response to stress re-exposure, which relies on their distinct impact in adult hippocampal neuroplasticity.
“We observed that pre-treatment with fluoxetine or imipramine confers a different profile of response to stress re-exposure, which relies on their distinct impact in adult hippocampal neuroplasticity.”
Quote in the paperSubstantial claim- Rests on an assumption: The unpredictable chronic mild stress (uCMS) protocol in rats models recurrent depression in humans.
- Premisecitation
At long-term, remission is mainly associated with a normalized production of newborn neurons in the adult hippocampal dentate gyrus.
“at long-term, remission is mainly associated to a normalized production of newborn neurons in the adult hippocampal dentate gyrus (DG).20”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [20] Mateus-Pinheiro A, Pinto L, Bessa JM, Morais M, Alves ND, Monteiro S et al. Sustained remission from depressive-like behavior depends on hippocampal neurogenesis. Transl Psychiatry 2013; 3: e210. source
Not checked in the free run.
- Interpretationown data
Proper control of adult hippocampal neuroplasticity triggered by antidepressants is essential to counteract recurrent depressive-like episodes.
“reveals that the proper control of adult hippocampal neuroplasticity triggered by antidepressants is essential to counteract recurrent depressive-like episodes.”
Quote in the paperSubstantial claim- Rests on an assumption: The unpredictable chronic mild stress (uCMS) protocol in rats models recurrent depression in humans.
- Interpretationown data
The maintenance of adult neurogenesis at certain levels was required to prevent behavior deficits induced by recurrent stress.
“In fact, the maintenance of adult neurogenesis at certain levels was required to prevent behavior deficits induced by recurrent stress, as the suppression of cell genesis by co-administration of MAM prevented the resilience to behavioral alterations on treatment with imipramine.”
Quote in the paperSubstantial claim - Interpretationown data
Normalization of adult neurogenesis and an enhancement of dendritic arborization confers protection to recurrent depression.
“whereas normalization of adult neurogenesis, and an enhancement of dendritic arborization, confers protection to recurrent depression.”
Quote in the paperSubstantial claim- Rests on an assumption: The uCMS protocol in animals is a valid model of recurrent depression in humans.
- Interpretationreasoning
The observed long-term increase in the arborization of DG granule neurons also accounts for the increased resistance to repeated stressful events.
“we here suggest that the observed long-term increase in the arborization of DG granule neurons also accounts for the increased resistance to repeated stressful events.”
Quote in the paperSubstantial claim - Interpretationcitation
Residual changes and reported impairments in DG synaptic plasticity may account for the re-appearance of depressive, anxiety and cognitive deficits on uCMS re-exposure.
“These residual changes, together with reported impairments in DG synaptic plasticity9, 28, 29 may account for the re-appearance of depressive, anxiety and cognitive deficits on uCMS re-exposure.”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [9] Bessa JM, Ferreira D, Melo I, Marques F, Cerqueira JJ, Palha JA et al. The mood-improving actions of antidepressants do not depend on neurogenesis but are associated with neuronal remodeling. Mol Psychiatry 2009; 14: 764–773, 739. source
Not checked in the free run.
- cites [28] Bisaz R, Sandi C . Vulnerability of conditional NCAM-deficient mice to develop stress-induced behavioral alterations. Stress 2012; 15: 195–206. source
Not checked in the free run.
- cites [29] Dagyte G, Luiten PG, De Jager T, Gabriel C, Mocaer E, Den Boer JA et al. Chronic stress and antidepressant agomelatine induce region-specific changes in synapsin I expression in the rat brain. J Neurosci Res 2011; 89: 1646–1657. source
Not checked in the free run.
- Premisecitation
Clinical studies show that remitted patients treated with fluoxetine present higher rates of relapse, in comparison with other ADs.
“in agreement with clinical studies showing that remitted patients treated with fluoxetine present higher rates of relapse, in comparison with other ADs.30, 31”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [30] Boland RJ, Keller MB . The course of depression. In: Davis KL, Charney D, Coyle JT, Nemeroff C (eds). Neuropsychopharmacology: The Fifth Generation of Progress. American College of Neuropsychopharmacology: Philadelphia, Pennsylvania, 2002, pp 1009–1015.
Not checked in the free run.
- cites [31] Sim K, Lau WK, Sim J, Sum MY, Baldessarini RJ . Prevention of relapse and recurrence in adults with major depressive disorder: systematic review and meta-analyses of controlled trials. Int J Neuropsychopharmacol 2016; 19: pii: pyv076. source
Not checked in the free run.
- Premisecitation
An aberrant increase in the generation of newborn neurons increases the competition for afferent inputs.
“increase the competition for afferent inputs33”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [33] Toni N, Teng EM, Bushong EA, Aimone JB, Zhao C, Consiglio A et al. Synapse formation on neurons born in the adult hippocampus. Nat Neurosci 2007; 10: 727–734. source
Not checked in the free run.
- Interpretationreasoning
Production and survival of adult-born neurons beyond a certain threshold can be detrimental for normal hippocampal function.
“and that production and survival of adult-born neurons beyond a certain threshold can be detrimental for normal hippocampal function.”
Quote in the paperSubstantial claim - Interpretationcitation
Re-establishment of adult hippocampal neurogenesis is required for a sustained remission from depressive-like behavior.
“our findings reinforce the view that re-establishment of adult hippocampal neurogenesis is required for a sustained remission from depressive-like behavior20”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [20] Mateus-Pinheiro A, Pinto L, Bessa JM, Morais M, Alves ND, Monteiro S et al. Sustained remission from depressive-like behavior depends on hippocampal neurogenesis. Transl Psychiatry 2013; 3: e210. source
Not checked in the free run.
- Interpretationown data
Abnormal adult neuroplasticity triggers distinct responses to recurrent exposure to uCMS.
“In addition, the present work is the first to show that abnormal adult neuroplasticity triggers distinct responses to recurrent exposure to uCMS: an exaggerated potentiation of adult neurogenesis and neuronal atrophy increases the susceptibility to specific behavioral deficits induced by recurrent stress exposure, whereas normalization of adult neurogenesis, and an enhancement of dendritic arboriz”
Quote in the paperSubstantial claim - Interpretationown data
Intact DG dendritic length and no alterations in the survival of newborn neurons may account for the observed resilience to anhedonic-like deficits.
“These animals present intact DG dendritic length and no alterations in the survival of newborn neurons, which may account for the observed resilience to anhedonic-like deficits.”
Quote in the paperSubstantial claim - Interpretationreasoning
The non-physiological potentiation of neurogenesis and the neuronal atrophy promoted by fluoxetine may trigger increased susceptibility to behavioral deficits in stress recurrence.
“Altogether, the non-physiological potentiation of neurogenesis and the neuronal atrophy promoted by fluoxetine may trigger increased susceptibility to behavioral deficits in stress recurrence, as shown here.”
Quote in the paperSubstantial claim - Interpretationreasoning
An exaggerated potentiation of adult neurogenesis and neuronal atrophy increases the susceptibility to specific behavioral deficits induced by recurrent stress exposure.
“an exaggerated potentiation of adult neurogenesis and neuronal atrophy increases the susceptibility to specific behavioral deficits induced by recurrent stress exposure”
Quote in the paperSubstantial claim - Premisecitation
An aberrant increase in the generation of newborn neurons increases depolarization in response to GABA-ergic inputs.
“and depolarization in response to GABA-ergic inputs.34”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [34] Ge S, Yang CH, Hsu KS, Ming GL, Song H . A critical period for enhanced synaptic plasticity in newly generated neurons of the adult brain. Neuron 2007; 54: 559–566. source
Not checked in the free run.
- Interpretationreasoning
Depletion of neural progenitors may explain why fluoxetine treatment did not restore the levels of neuronal differentiation.
“Despite the attempt to potentiate the neurogenic process, denoted by the increased expression of neuronal maturation-related markers, fluoxetine treatment was not able to restore the levels of neuronal differentiation possibly due to the depletion of neural progenitors.”
Quote in the paperSubstantial claim
- May combine two claims. 21
- Classified as probably not a substantial claim. 24
May combine two claims.
Findingown dataFluoxetine-treated animals presented a marked decrease in the number of neuroblasts, contrarily to imipramine-treated animals.
“Fluoxetine-treated animals also presented a marked decrease in the number of neuroblasts, contrarily to those treated with imipramine (Figure 3j).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown datauCMS exposure increased anxiety-like behavior in the elevated-plus maze, which was partially rescued by both antidepressants.
“uCMS exposure increased anxiety-like behavior in the elevated-plus maze as previously described,9, 20 which was partially rescued by both ADs (tp1: P=0.0071; F2,14=3.264, P=0.0686; FLX: post hoc P=0.0981; IMIP: post hoc P>0.1, Figure 1f)”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataThe effect of fluoxetine on newborn cells was neuronal-specific, with no alterations in newborn astroglial cells or expression of astroglial differentiation promoting factors STAT3 and BMP4.
“this effect was neuronal-specific, as no alterations were found in the number of newborn astroglial cells (identified as BrdU+GFAP+ cells; Figures 3d and e) and in the expression analysis of astroglial differentiation promoting factors, STAT3 and BMP4 (Figure 3f)”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataImpairments in spatial behavioral flexibility promoted by uCMS re-exposure in non-treated animals were prevented by fluoxetine but not by imipramine.
“impairments in spatial behavioral flexibility promoted by uCMS re-exposure in non-treated animals (P=0.0018, Figure 2f) were only prevented by fluoxetine, but not by imipramine (F2,13=7.521, P=0.0068; FLX: post hoc P=0.0264; IMIP: post hoc P>0.1, Figure 2f)”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataThese animals present intact DG dendritic length and no alterations in the survival of newborn neurons.
“These animals present intact DG dendritic length and no alterations in the survival of newborn neurons, which may account for the observed resilience to anhedonic-like deficits.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataRecurrent uCMS exposure potentiated the re-appearance of depressive- and anxiety-like behaviors as well as cognitive deficits.
“Noticeably, we showed that recurrent uCMS exposure potentiated the re-appearance of depressive- and anxiety-like behaviors as well as cognitive deficits.”
Quote in the paperSubstantial claim- Rests on an assumption: The uCMS protocol in animals is a valid model of recurrent depression in humans.
Probably not a substantial claim: may not pass S3 (load-bearing).
FindingcitationCell proliferation arrestment by MAM impacts anxiety-like behavior of non-stressed animals.
“Of notice, as previously observed,20, 22, 27 cell proliferation arrestment by MAM impacts anxiety-like behavior of non-stressed animals (Supplementary Figure 3).”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [20] Mateus-Pinheiro A, Pinto L, Bessa JM, Morais M, Alves ND, Monteiro S et al. Sustained remission from depressive-like behavior depends on hippocampal neurogenesis. Transl Psychiatry 2013; 3: e210. source
Not checked in the free run.
- cites [22] Li YF, Huang Y, Amsdell SL, Xiao L, O'Donnell JM, Zhang HT . Antidepressant- and anxiolytic-like effects of the phosphodiesterase-4 inhibitor rolipram on behavior depend on cyclic AMP response element binding protein-mediated neurogenesis in the hippocampus. Neuropsychopharmacology 2009; 34: 2404–2419. source
Not checked in the free run.
- cites [27] Hsiao YH, Hung HC, Chen SH, Gean PW . Social interaction rescues memory deficit in an animal model of Alzheimer's disease by increasing BDNF-dependent hippocampal neurogenesis. J Neurosci 2014; 34: 16207–16219. source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
FindingcitationTreatment with fluoxetine and imipramine promoted a sustained remission of an initial depressive-like state.
“In accordance to previous reports, we observed that treatment with fluoxetine and imipramine promoted a sustained remission of an initial depressive-like state and a re-establishment of the hippocampal neurogenic process.20”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [20] Mateus-Pinheiro A, Pinto L, Bessa JM, Morais M, Alves ND, Monteiro S et al. Sustained remission from depressive-like behavior depends on hippocampal neurogenesis. Transl Psychiatry 2013; 3: e210. source
Not checked in the free run.
- Rests on an assumption: The effects of fluoxetine and imipramine in the uCMS animal model predict their effects in human recurrent depression.
May combine two claims.
Findingown dataAnimals treated with fluoxetine during the initial uCMS exposure presented an increased susceptibility to anhedonic-like behavior once re-exposed to uCMS, in contrast to non-treated animals, which did not present an anhedonic phenotype.
“Results revealed that animals treated with fluoxetine during the initial uCMS exposure presented an increased susceptibility to anhedonic-like behavior once re-exposed to uCMS, in contrast to non-treated animals, which did not present an anhedonic phenotype.”
Quote in the paperSubstantial claim- Rests on an assumption: The uCMS protocol in animals is a valid model of recurrent depression in humans.
- Rests on an assumption: The effects of fluoxetine and imipramine in the uCMS animal model predict their effects in human recurrent depression.
May combine two claims.
FindingcitationThis behavioral resilience to repeated uCMS was associated with a normalization of the hippocampal neurogenic process and with a robust increase in the dendritic arborization of DG granule neurons.
“This behavioral resilience to repeated uCMS was associated with a normalization of the hippocampal neurogenic process,20 but also with a robust increase in the dendritic arborization of DG granule neurons (Figure 5g).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [20] Mateus-Pinheiro A, Pinto L, Bessa JM, Morais M, Alves ND, Monteiro S et al. Sustained remission from depressive-like behavior depends on hippocampal neurogenesis. Transl Psychiatry 2013; 3: e210. source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
FindingcitationTreatment with fluoxetine and imipramine promoted a re-establishment of the hippocampal neurogenic process.
“In accordance to previous reports, we observed that treatment with fluoxetine and imipramine promoted a sustained remission of an initial depressive-like state and a re-establishment of the hippocampal neurogenic process.20”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [20] Mateus-Pinheiro A, Pinto L, Bessa JM, Morais M, Alves ND, Monteiro S et al. Sustained remission from depressive-like behavior depends on hippocampal neurogenesis. Transl Psychiatry 2013; 3: e210. source
Not checked in the free run.
May combine two claims.
Findingown dataTreatment with fluoxetine was inefficient in preventing the detrimental behavioral consequences induced by stress re-exposure, including depressive- and anxiety-like behavior as well as cognitive deficits (long-term memory), with the exception of a specific cognitive task (behavioral flexibility).
“Moreover, treatment with fluoxetine was inefficient in preventing the detrimental behavioral consequences induced by stress re-exposure, including depressive- and anxiety-like behavior as well as cognitive deficits (long-term memory) with the exception of a specific cognitive task (behavioral flexibility).”
Quote in the paperSubstantial claim- Rests on an assumption: The uCMS protocol in animals is a valid model of recurrent depression in humans.
- Rests on an assumption: The effects of fluoxetine and imipramine in the uCMS animal model predict their effects in human recurrent depression.
May combine two claims.
Findingown dataMAM administration in animals re-exposed to uCMS and co-treated with fluoxetine induced a significant reduction in the number of BrdU+NeuN+ cells, preventing the increased neurogenesis promoted by fluoxetine.
“As expected, MAM administration in animals re-exposed to uCMS and co-treated with fluoxetine induced a significant reduction in the number of BrdU+NeuN+ cells, preventing the increased neurogenesis promoted by fluoxetine (FLX vs FLX+MAM: P=0.0303, Figure 5b).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataThese behavioral alterations were correlated with normal levels of survival of newborn neurons, with the exception of synaptic plasticity that showed persistent impairments after recurrent stress exposure.
“Moreover, these behavioral alterations were correlated with normal levels of survival of newborn neurons with exception of synaptic plasticity that showed persistent impairments after recurrent stress exposure.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductcitationSample sizes were based on previous published studies.
“The sample sizes were based on previous published studies.9, 20”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [9] Bessa JM, Ferreira D, Melo I, Marques F, Cerqueira JJ, Palha JA et al. The mood-improving actions of antidepressants do not depend on neurogenesis but are associated with neuronal remodeling. Mol Psychiatry 2009; 14: 764–773, 739. source
Not checked in the free run.
- cites [20] Mateus-Pinheiro A, Pinto L, Bessa JM, Morais M, Alves ND, Monteiro S et al. Sustained remission from depressive-like behavior depends on hippocampal neurogenesis. Transl Psychiatry 2013; 3: e210. source
Not checked in the free run.
May combine two claims.
PremisecitationAdult cytogenesis (neurogenesis and gliogenesis) and morphological changes in the hippocampus are altered by chronic stress and reverted by antidepressants.
“neuroplastic events, including adult cytogenesis (neurogenesis9, 10, 11 and gliogenesis12) and morphological changes, are described to be altered by chronic stress and reverted by antidepressants (ADs).13, 14”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [13] Surget A, Tanti A, Leonardo ED, Laugeray A, Rainer Q, Touma C et al. Antidepressants recruit new neurons to improve stress response regulation. Mol Psychiatry 2011; 16: 1177–1188. source
Not checked in the free run.
- cites [14] Patricio P, Mateus-Pinheiro A, Irmler M, Alves ND, Machado-Santos AR, Morais M et al. Differential and converging molecular mechanisms of antidepressants' action in the hippocampal dentate gyrus. Neuropsychopharmacology 2014; 40: 338–349. source
Not checked in the free run.
May combine two claims.
Interpretationown dataImipramine re-established hippocampal neurogenesis and neuronal dendritic arborization, contributing to resilience to recurrent depressive-like behavior.
“while imipramine re-established hippocampal neurogenesis and neuronal dendritic arborization contributing to resilience to recurrent depressive-like behavior”
Quote in the paperSubstantial claim- Rests on an assumption: The unpredictable chronic mild stress (uCMS) protocol in rats models recurrent depression in humans.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationAnimals subjected to stress during adolescence are resilient to depressive- and anxiety-like behavior on chronic stress re-exposure in adulthood.
“animals subjected to stress during adolescence were resilient to depressive- and anxiety-like behavior on chronic stress re-exposure in adulthood7”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [7] Suo L, Zhao L, Si J, Liu J, Zhu W, Chai B et al. Predictable chronic mild stress in adolescence increases resilience in adulthood. Neuropsychopharmacology 2013; 38: 1387–1400. source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationRe-exposure to stress is associated with altered expression of cytoskeletal proteins.
“the deleterious effects evoked by re-exposure to stress were associated to altered expression of cytoskeletal proteins.6”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [6] Yang C, Wang G, Wang H, Liu Z, Wang X . Cytoskeletal alterations in rat hippocampus following chronic unpredictable mild stress and re-exposure to acute and chronic unpredictable mild stress. Behav Brain Res 2009; 205: 518–524. source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenRats were randomly divided into six experimental groups.
“Rats (n=6–8 for behavioral analysis, of which three to four were considered for gene expression quantification, immunofluorescence and neuromorphologic studies) from two independent sets were randomly divided into six groups”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductcitationThe uCMS protocol used was validated and previously described.
“Rats were subjected to a validated uCMS protocol for 6 weeks, as previously described9, 20, 23”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [9] Bessa JM, Ferreira D, Melo I, Marques F, Cerqueira JJ, Palha JA et al. The mood-improving actions of antidepressants do not depend on neurogenesis but are associated with neuronal remodeling. Mol Psychiatry 2009; 14: 764–773, 739. source
Not checked in the free run.
- cites [20] Mateus-Pinheiro A, Pinto L, Bessa JM, Morais M, Alves ND, Monteiro S et al. Sustained remission from depressive-like behavior depends on hippocampal neurogenesis. Transl Psychiatry 2013; 3: e210. source
Not checked in the free run.
- cites [23] Willner P . Chronic mild stress (CMS) revisited: consistency and behavioural-neurobiological concordance in the effects of CMS. Neuropsychobiology 2005; 52: 90–110. source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationAt short-term, behavioral improvements induced by antidepressants rely on hippocampal neuronal remodeling.
“at short-term, behavioral improvements induced by ADs rely on hippocampal neuronal remodeling,9”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [9] Bessa JM, Ferreira D, Melo I, Marques F, Cerqueira JJ, Palha JA et al. The mood-improving actions of antidepressants do not depend on neurogenesis but are associated with neuronal remodeling. Mol Psychiatry 2009; 14: 764–773, 739. source
Not checked in the free run.
May combine two claims.
Interpretationown dataStress re-exposure in fluoxetine-treated animals resulted in an overproduction of adult-born neurons along with neuronal atrophy of granule neurons, accounting for an increased susceptibility to recurrent behavioral changes typical of depression.
“stress re-exposure in fluoxetine-treated animals resulted in an overproduction of adult-born neurons along with neuronal atrophy of granule neurons, accounting for an increased susceptibility to recurrent behavioral changes typical of depression.”
Quote in the paperSubstantial claim- Rests on an assumption: The unpredictable chronic mild stress (uCMS) protocol in rats models recurrent depression in humans.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationOver 85% of remitted patients suffer recurrent episodes of depression within 15 years after an initial event.
“over 85% of remitted patients suffer recurrent episodes of depression, within 15 years after an initial event.2, 3”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [2] Mueller TI, Leon AC, Keller MB, Solomon DA, Endicott J, Coryell W et al. Recurrence after recovery from major depressive disorder during 15 years of observational follow-up. Am J Psychiatry 1999; 156: 1000–1006. source
Not checked in the free run.
- cites [3] Baldessarini RJ, Lau WK, Sim J, Sum MY, Sim K . Duration of initial antidepressant treatment and subsequent relapse of major depression. J Clin Psychopharmacol 2015; 35: 75–76. source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationRecurrent depression has been associated with the persistence of subclinical residual symptoms and the number of previous episodes.
“recurrent depression has also been associated to the persistence of subclinical residual symptoms and the number of previous episodes.5”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [5] Hardeveld F, Spijker J, De Graaf R, Nolen WA, Beekman AT . Prevalence and predictors of recurrence of major depressive disorder in the adult population. Acta Psychiatr Scand 2010; 122: 184–191. source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationNeuroplastic processes and their disturbances have behavioral repercussions in cognitive and emotional dimensions in both physiological and pathological conditions including schizophrenia and depressive disorders.
“Neuroplastic processes, and particularly its disturbances, have behavioral repercussions in cognitive and emotional dimensions in both physiological15 and pathological conditions including schizophrenia16 and depressive disorders.17, 18, 19”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [17] Mateus-Pinheiro A, Patricio P, Bessa JM, Sousa N, Pinto L . Cell genesis and dendritic plasticity: a neuroplastic pas de deux in the onset and remission from depression. Mol Psychiatry 2013; 8: 748–750. source
Not checked in the free run.
- cites [18] Bessa JM, Mesquita AR, Oliveira M, Pego JM, Cerqueira JJ, Palha JA et al. A trans-dimensional approach to the behavioral aspects of depression. Front Behav Neurosci 2009; 3: 1. source
Not checked in the free run.
- cites [19] Sahay A, Hen R . Adult hippocampal neurogenesis in depression. Nat Neurosci 2007; 10: 1110–1115. source
Not checked in the free run.
May combine two claims.
InterpretationreasoningPrevious stressful events may have short-term detrimental effects on cortico-limbic plasticity but also confer protection against certain behavioral and neuroplastic deficits after recurrent stressful situations.
“Our findings put forward the understanding how previous stressful events may have short-term detrimental effects on cortico-limbic plasticity but also highlight their importance in conferring protection against certain behavioral and neuroplastic deficits after recurrent stressful situations.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationAn aberrant increase in the generation of newborn neurons enhances plasticity and excitability.
“In fact, an aberrant increase in the generation of newborn neurons was shown to enhance plasticity and excitability,32”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [32] Schmidt-Hieber C, Jonas P, Bischofberger J . Enhanced synaptic plasticity in newly generated granule cells of the adult hippocampus. Nature 2004; 429: 184–187. source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationAnimal studies report behavioral deficits in fluoxetine-treated animals re-exposed to stress.
“these results seem to be in accordance with animal studies reporting behavioral deficits in fluoxetine-treated animals re-exposed to stress6”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [6] Yang C, Wang G, Wang H, Liu Z, Wang X . Cytoskeletal alterations in rat hippocampus following chronic unpredictable mild stress and re-exposure to acute and chronic unpredictable mild stress. Behav Brain Res 2009; 205: 518–524. source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationSpatial reversal learning is not exclusively associated with hippocampal function but also with the prefrontal cortex, namely the prelimbic and infralimbic, and orbitalfrontal regions.
“This particular cognitive task is not exclusively associated with hippocampal function but also the prefrontal cortex,42 namely the prelimbic and infralimbic, and orbitalfrontal regions;43”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [42] Clark L, Cools R, Robbins TW . The neuropsychology of ventral prefrontal cortex: decision-making and reversal learning. Brain Cogn 2004; 55: 41–53. source
Not checked in the free run.
- cites [43] McAlonan K, Brown VJ . Orbital prefrontal cortex mediates reversal learning and not attentional set shifting in the rat. Behav Brain Res 2003; 146: 97–103. source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
InterpretationcitationThe contribution of other brain regions, such as the nucleus accumbens, cannot be excluded from this anhedonic resilience.
“However, the contribution of other brain regions, such as the nucleus accumbens, cannot be excluded of this anhedonic resilience, given the previous association between stress-induced anhedonia and medium spiny neurons”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [25] Bessa JM, Morais M, Marques F, Pinto L, Palha JA, Almeida OF et al. Stress-induced anhedonia is associated with hypertrophy of medium spiny neurons of the nucleus accumbens. Transl Psychiatry 2013; 3: e266. source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenNo data points were excluded from the different analyses.
“No data points were excluded from the different analyses.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim. May combine two claims.
PremisecitationADs, including imipramine, reverse the shrinkage in dendritic branching induced by stress and allow the re-establishment of the normal neuronal network.
“in line with previous studies demonstrating that ADs, including imipramine, reverse the shrinkage in dendritic branching induced by stress and allows the re-establishment of the normal neuronal network,9”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [9] Bessa JM, Ferreira D, Melo I, Marques F, Cerqueira JJ, Palha JA et al. The mood-improving actions of antidepressants do not depend on neurogenesis but are associated with neuronal remodeling. Mol Psychiatry 2009; 14: 764–773, 739. source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationImipramine is known to confer protection to depressive-like behavior through an increase in the dendritic arborization of immature neurons.
“Likewise, imipramine is also known to confer protection to depressive-like behavior through an increase in the dendritic arborization of immature neurons.46”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [46] Fenton EY, Fournier NM, Lussier AL, Romay-Tallon R, Caruncho HJ, Kalynchuk LE . Imipramine protects against the deleterious effects of chronic corticosterone on depression-like behavior, hippocampal reelin expression, and neuronal maturation. Prog Neuropsychopharmacol Biol Psychiatry 2015; 60: 52–59. source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationPrevious studies suggest a strong impact of hippocampal structural alterations in the susceptibility to depression and an important contribution for recurrent episodes.
“Importantly, previous studies also suggested a strong impact of hippocampal structural alterations in the susceptibility to depression40 and an important contribution for recurrent episodes.41”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [40] Chan SW, Harmer CJ, Norbury R, O'Sullivan U, Goodwin GM, Portella MJ . Hippocampal volume in vulnerability and resilience to depression. J Affect Disord 2016; 189: 199–202. source
Not checked in the free run.
- cites [41] Sheline YI, Wang PW, Gado MH, Csernansky JG, Vannier MW . Hippocampal atrophy in recurrent major depression. Proc Natl Acad Sci USA 1996; 93: 3908–3913. source
Not checked in the free run.
Classified as probably not a substantial claim.
PremisecitationPrevious studies have shown an increased anxiety-like phenotype in consequence of increased neurogenesis induced by voluntary wheel running.
“Moreover, previous studies have shown an increased anxiety-like phenotype in consequence of increased neurogenesis induced by voluntary wheel running.37, 38, 39”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [37] Fuss J, Ben Abdallah NM, Vogt MA, Touma C, Pacifici PG, Palme R et al. Voluntary exercise induces anxiety-like behavior in adult C57BL/6J mice correlating with hippocampal neurogenesis. Hippocampus 2010; 20: 364–376. source
Not checked in the free run.
- cites [38] Fuss J, Ben Abdallah NM, Hensley FW, Weber KJ, Hellweg R, Gass P . Deletion of running-induced hippocampal neurogenesis by irradiation prevents development of an anxious phenotype in mice. PLoS ONE 2010; 5: pii: e12769. source
Not checked in the free run.
- cites [39] Onksen JL, Briand LA, Galante RJ, Pack AI, Blendy JA . Running-induced anxiety is dependent on increases in hippocampal neurogenesis. Genes Brain Behav 2012; 11: 529–538. source
Not checked in the free run.
Classified as probably not a substantial claim.
Study design and conductown dataAll presented data satisfied normal distribution in Kolmogorov-Smirnov testing.
“All presented data satisfied normal distribution in Kolmogorov–Smirnov testing.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
InterpretationreasoningThere is the possibility that fluoxetine treatment may positively affect these prefrontal regions accounting for the observed resilience of reversal learning deficits.
“thus, there is the possibility that fluoxetine treatment may positively affect these prefrontal regions accounting to the observed resilience of reversal learning deficits.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenData were subjected to appropriate statistical tests after confirmation of homogeneity of group variances between the groups.
“After confirmation of homogeneity of group variances between the groups, data were subjected to appropriate statistical tests.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S2 (checkable).
InterpretationreasoningAdult neuroplasticity changes induced by stress and ADs must be finely tuned to prevent recurrence in depression.
“In essence, these findings reflect how adult neuroplasticity changes induced by stress and ADs must be finely tuned to prevent recurrence in depression.”
Quote in the paperNot a substantial claim- Rests on an assumption: The uCMS protocol in animals is a valid model of recurrent depression in humans.
- Rests on an assumption: The effects of fluoxetine and imipramine in the uCMS animal model predict their effects in human recurrent depression.
May combine two claims.
InterpretationcitationSuch alterations promote an increased participation of these cells during learning and memory tasks and a reconfiguration of DG-CA3 circuits that degrade stored memories.
“Consequently, such alterations promote an increased participation of these cells during learning and memory tasks35 and a reconfiguration of DG-CA3 circuits that degrade stored memories.36”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [35] Kee N, Teixeira CM, Wang AH, Frankland PW . Preferential incorporation of adult-generated granule cells into spatial memory networks in the dentate gyrus. Nat Neurosci 2007; 10: 355–362. source
Not checked in the free run.
- cites [36] Akers KG, Martinez-Canabal A, Restivo L, Yiu AP, De Cristofaro A, Hsiang HL et al. Hippocampal neurogenesis regulates forgetting during adulthood and infancy. Science 2014; 344: 598–602. source
Not checked in the free run.
The paper relies on this without support.
The unpredictable chronic mild stress (uCMS) protocol in rats models recurrent depression in humans.
“Through re-exposure to an unpredictable chronic mild stress protocol in rats, we observed the re-appearance of emotional and cognitive deficits.”
The paper relies on this without support.
The behavioral tests used (sucrose preference, forced-swimming, elevated-plus maze, novelty-suppressed feeding, novel object recognition, Morris water maze) measure the intended emotional and cognitive domains in rats.
“behavior was continuously monitored for depressive- and anhedonic-like behavior, anxiety and cognition (Figure 1a).”
The paper relies on this without support.
A 4-week stress-free period is sufficient to model remission from a depressive-like episode.
“For the following 4 weeks after uCMS, animals were not subjected to any stressor.”
The paper relies on this without support.
The uCMS protocol in animals is a valid model of recurrent depression in humans.
“using a well-established animal model of depression”
The paper relies on this without support.
The effects of fluoxetine and imipramine in the uCMS animal model predict their effects in human recurrent depression.
“in agreement with clinical studies showing that remitted patients treated with fluoxetine present higher rates of relapse, in comparison with other ADs.30, 31”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Treatment with the antidepressant fluoxetine results in an overproduction of new neurons in the adult hippocampus, associated with cognitive decline, increased susceptibility to stress-induced depression, and excessive anxiety.
“Treatment with the antidepressant fluoxetine resulted in an overproduction of new neurons in the adult hippocampus (Alves et al., 2017) (Table 1). This effect, which at first glance appeared to be beneficial, was surprisingly associated with cognitive decline, as well as increased susceptibility to stress-induced depression and excessive anxiety (Alves et al., 2017).”
From Adult neurogenesis, glia, and the extracellular matrix (2019) · cites this paper as Alves et al., 2017
Pharmacological blockade of adult neurogenesis rescues the deleterious behavioral effects induced by antidepressant treatment, strongly suggesting that in this case the new neurons impaired hippocampal function.
“Pharmacological blockade of adult neurogenesis rescued the deleterious behavioral effects induced by antidepressant treatment strongly suggesting that in this case, the new neurons impaired hippocampal function (Alves et al., 2017).”
From Adult neurogenesis, glia, and the extracellular matrix (2019) · cites this paper as Alves et al., 2017
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Novel-object test F statistic contradicts its reported P value
MajorAn F statistic of 1.482 with 2 and 29 degrees of freedom has a P value of approximately 0.244, not less than 0.0001. This discrepancy affects the reported significance of the treatment-group comparison at tp3.
“F2,29=1.482”
“P<0.0001; FLX: post hoc P>0.99; IMIP: post hoc P=0.0001, Figure 2c”
Cites
Analyzing real-time PCR data by the comparative CT method
Schmittgen, T. D., & Livak, K. J. (2008) · Nature Protocols · doi:10.1038/nprot.2008.73 · Cited by 26,190 · see citing works
Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants
Santarelli, L., Saxe, M., Gross, C., Surget, A., Battaglia, F., Dulawa, S., Weisstaub, N., Lee, J., Duman, R., Arancio, O., et al. (2003) · Science · doi:10.1126/science.1083328 · Cited by 4,321 · see citing works
Hippocampal atrophy in recurrent major depression
Sheline, Y. I., Wang, P. W., Gado, M. H., Csernansky, J. G., & Vannier, M. W. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.9.3908 · Cited by 1,932 · see citing works
Willner, P. (2005) · Neuropsychobiology · doi:10.1159/000087097 · Cited by 1,605 · see citing works
Enhanced synaptic plasticity in newly generated granule cells of the adult hippocampus
Schmidt-Hieber, C., Jonas, P., & Bischofberger, J. (2004) · Nature · doi:10.1038/nature02553 · Cited by 1,292 · see citing works
Adult hippocampal neurogenesis in depression
Sahay, A., & Hen, R. (2007) · Nature Neuroscience · doi:10.1038/nn1969 · Cited by 1,206 · see citing works
Neuropsychopharmacology: The Fifth Generation of Progress
Sagduyu, K. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.7.1251-a · Cited by 1,023 · see citing works
A Critical Period for Enhanced Synaptic Plasticity in Newly Generated Neurons of the Adult Brain
Ge, S., Yang, C.-H., Hsu, K.-S., Ming, G.-L., & Song, H. (2007) · Neuron · doi:10.1016/j.neuron.2007.05.002 · Cited by 927 · see citing works
Recurrence after recovery from major depressive disorder during 15 years of observational follow-up
Mueller, T. I., Leon, A. C., Keller, M. B., Solomon, D. A., Endicott, J., Coryell, W., Warshaw, M., & Maser, J. D. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.7.1000 · Cited by 897 · see citing works
The science of resilience: implications for the prevention and treatment of depression
Southwick, S. M., & Charney, D. S. (2012) · Science · doi:10.1126/science.1222942 · Cited by 875 · see citing works
Kee, N., Teixeira, C. M., Wang, A. H., & Frankland, P. W. (2007) · Nature Neuroscience · doi:10.1038/nn1847 · Cited by 875 · see citing works
Hippocampal Neurogenesis Regulates Forgetting During Adulthood and Infancy
Akers, K. G., Martinez-Canabal, A., Restivo, L., Yiu, A. P., De Cristofaro, A., Hsiang, H.-L. (., Wheeler, A. L., Guskjolen, A., Niibori, Y., Shoji, H., et al. (2014) · Science · doi:10.1126/science.1248903 · Cited by 761 · see citing works
Differential Control of Learning and Anxiety along the Dorsoventral Axis of the Dentate Gyrus
Kheirbek, M. A., Drew, L. J., Burghardt, N. S., Costantini, D. O., Tannenholz, L., Ahmari, S. E., Zeng, H., Fenton, A. A., & Hen, R. (2013) · Neuron · doi:10.1016/j.neuron.2012.12.038 · Cited by 713 · see citing works
Orbital prefrontal cortex mediates reversal learning and not attentional set shifting in the rat
McAlonan, K., & Brown, V. J. (2003) · Behavioural Brain Research · doi:10.1016/j.bbr.2003.09.019 · Cited by 618 · see citing works
Bessa, J. M., Ferreira, D., Melo, I., Marques, F., Cerqueira, J. J., Palha, J. A., Almeida, O. F. X., & Sousa, N. (2009) · Molecular Psychiatry · doi:10.1038/mp.2008.119 · Cited by 598 · see citing works
Self-citationSynapse formation on neurons born in the adult hippocampus
Toni, N., Teng, E. M., Bushong, E. A., Aimone, J. B., Zhao, C., Consiglio, A., van Praag, H., Martone, M. E., Ellisman, M. H., & Gage, F. H. (2007) · Nature Neuroscience · doi:10.1038/nn1908 · Cited by 579 · see citing works
Surget, A., Saxe, M., Leman, S., Ibarguen-Vargas, Y., Chalon, S., Griebel, G., Hen, R., & Belzung, C. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.02.022 · Cited by 556 · see citing works
Prevalence and predictors of recurrence of major depressive disorder in the adult population
Hardeveld, F., Spijker, J., De Graaf, R., Nolen, W. A., & Beekman, A. T. F. (2010) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2009.01519.x · Cited by 486 · see citing works
Antidepressants recruit new neurons to improve stress response regulation
Surget, A., Tanti, A., Leonardo, E. D., Laugeray, A., Rainer, Q., Touma, C., Palme, R., Griebel, G., Ibarguen-Vargas, Y., Hen, R., et al. (2011) · Molecular Psychiatry · doi:10.1038/mp.2011.48 · Cited by 471 · see citing works
A trans-dimensional approach to the behavioral aspects of depression
Bessa, J. M. (2009) · Frontiers in Behavioral Neuroscience · doi:10.3389/neuro.08.001.2009 · Cited by 469 · see citing works
Self-citationThe neuropsychology of ventral prefrontal cortex: Decision-making and reversal learning
Clark, L., Cools, R., & Robbins, T. W. (2004) · Brain and Cognition · doi:10.1016/s0278-2626(03)00284-7 · Cited by 439 · see citing works
Recognizing resilience: Learning from the effects of stress on the brain
McEwen, B. S., Gray, J. D., & Nasca, C. (2015) · Neurobiology of Stress · doi:10.1016/j.ynstr.2014.09.001 · Cited by 292 · see citing works
Fuss, J., Ben Abdallah, N. M. ‐., Vogt, M. A., Touma, C., Pacifici, P. G., Palme, R., Witzemann, V., Hellweg, R., & Gass, P. (2010) · Hippocampus · doi:10.1002/hipo.20634 · Cited by 240 · see citing works
Sim, K., Lau, W. K., Sim, J., Sum, M. Y., & Baldessarini, R. J. (2016) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyv076 · Cited by 218 · see citing works
Interplay between DISC1 and GABA Signaling Regulates Neurogenesis in Mice and Risk for Schizophrenia
Kim, J., Liu, C. Y., Zhang, F., Duan, X., Wen, Z., Song, J., Feighery, E. L., Lu, B., Rujescu, D., Clair, D. S., et al. (2012) · Cell · doi:10.1016/j.cell.2011.12.037 · Cited by 207 · see citing works
Li, Y.-F., Huang, Y., Amsdell, S. L., Xiao, L., O'Donnell, J. M., & Zhang, H.-T. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2009.66 · Cited by 185 · see citing works
Sustained remission from depressive-like behavior depends on hippocampal neurogenesis
Mateus-Pinheiro, A., Pinto, L., Bessa, J. M., Morais, M., Alves, N. D., Monteiro, S., Patrício, P., Almeida, O. F. X., & Sousa, N. (2013) · Translational Psychiatry · doi:10.1038/tp.2012.141 · Cited by 149 · see citing works
Self-citationHsiao, Y.-H., Hung, H.-C., Chen, S.-H., & Gean, P.-W. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.0747-14.2014 · Cited by 130 · see citing works
Bessa, J. M., Morais, M., Marques, F., Pinto, L., Palha, J. A., Almeida, O. F. X., & Sousa, N. (2013) · Translational Psychiatry · doi:10.1038/tp.2013.39 · Cited by 130 · see citing works
Self-citationAntidepressants act directly on astrocytes: Evidences and functional consequences
Czéh, B., & Benedetto, B. D. (2012) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2012.04.017 · Cited by 129 · see citing works
Predictable chronic mild stress in adolescence increases resilience in adulthood
Suo, L., Zhao, L., Si, J., Liu, J., Zhu, W., Chai, B., Zhang, Y., Feng, J., Ding, Z., Luo, Y., et al. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.67 · Cited by 122 · see citing works
Hollon, S. D., Shelton, R. C., Wisniewski, S., Warden, D., Biggs, M. M., Friedman, E. S., Husain, M., Kupfer, D. J., Nierenberg, A. A., Petersen, T. J., et al. (2006) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2005.07.008 · Cited by 120 · see citing works
Simons, A. D., Angell, K. L., Monroe, S. M., & Thase, M. E. (1993) · Journal of Abnormal Psychology · doi:10.1037/0021-843x.102.4.584 · Cited by 115 · see citing works
Fuss, J., Ben Abdallah, N. M. B., Hensley, F. W., Weber, K.-J., Hellweg, R., & Gass, P. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012769 · Cited by 110 · see citing works
Hippocampal volume in vulnerability and resilience to depression
Chan, S. W. Y., Harmer, C. J., Norbury, R., O’Sullivan, U., Goodwin, G. M., & Portella, M. J. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.09.021 · Cited by 101 · see citing works
Jayatissa, M. N., Henningsen, K., West, M. J., & Wiborg, O. (2009) · Brain Research · doi:10.1016/j.brainres.2009.07.001 · Cited by 79 · see citing works
Fenton, E. Y., Fournier, N. M., Lussier, A. L., Romay-Tallon, R., Caruncho, H. J., & Kalynchuk, L. E. (2015) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2015.02.001 · Cited by 69 · see citing works
Yang, C., Wang, G., Wang, H., Liu, Z., & Wang, X. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2009.08.008 · Cited by 66 · see citing works
Patrício, P., Mateus-Pinheiro, A., Irmler, M., Alves, N. D., Machado-Santos, A. R., Morais, M., Correia, J. S., Korostynski, M., Piechota, M., Stoffel, R., et al. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2014.176 · Cited by 57 · see citing works
Self-citationDuration of Initial Antidepressant Treatment and Subsequent Relapse of Major Depression
Baldessarini, R. J., Lau, W. K., Sim, J., Sum, M. Y., & Sim, K. (2015) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000263 · Cited by 52 · see citing works
The Sweet Drive Test: refining phenotypic characterization of anhedonic behavior in rodents
Mateus‐Pinheiro, A., PatrÃcio, P., Alves, N. D., Machado-Santos, A. R., Morais, M., Bessa, J. M., Sousa, N., & Pinto, L. (2014) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2014.00074 · Cited by 48 · see citing works
Self-citationHornstra, R. K., & Klassen, D. (1977) · Comprehensive Psychiatry · doi:10.1016/0010-440x(77)90054-2 · Cited by 45 · see citing works
Dagyte, G., Luiten, P. G., De Jager, T., Gabriel, C., Mocaër, E., Den Boer, J. A., & Van der Zee, E. A. (2011) · Journal of Neuroscience Research · doi:10.1002/jnr.22697 · Cited by 32 · see citing works
Running‐induced anxiety is dependent on increases in hippocampal neurogenesis
Onksen, J. L., Briand, L. A., Galante, R. J., Pack, A. I., & Blendy, J. A. (2012) · Genes, Brain and Behavior · doi:10.1111/j.1601-183x.2012.00788.x · Cited by 29 · see citing works
Mateus-Pinheiro, A., Patrício, P., Bessa, J. M., Sousa, N., & Pinto, L. (2013) · Molecular Psychiatry · doi:10.1038/mp.2013.56 · Cited by 29 · see citing works
Self-citationVulnerability of conditional NCAM-deficient mice to develop stress-induced behavioral alterations
Bisaz, R., & Sandi, C. (2012) · Stress · doi:10.3109/10253890.2011.608226 · Cited by 28 · see citing works
Adolescent but not adult-born neurons are critical for susceptibility to chronic social defeat
Kirshenbaum, G. S., Lieberman, S. R., Briner, T. J., Leonardo, E. D., & Dranovsky, A. (2014) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2014.00289 · Cited by 23 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Antoniuk, S., Bijata, M., Ponimaskin, E., & Wlodarczyk, J. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.12.002 · Cited by 750 · see citing works
Animal models of major depression: drawbacks and challenges
Planchez, B., Surget, A., & Belzung, C. (2019) · Journal of Neural Transmission · doi:10.1007/s00702-019-02084-y · Cited by 480 · see citing works
Recognizing Depression from the Microbiota–Gut–Brain Axis
Liang, S., Wu, X., Hu, X., Wang, T., & Jin, F. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19061592 · Cited by 387 · see citing works
Adult neurogenesis, glia, and the extracellular matrix
Cope, E. C., & Gould, E. (2019) · Cell Stem Cell · doi:10.1016/j.stem.2019.03.023 · Cited by 236 · see citing works
Liu, H., Zhang, C., Ji, Y., & Yang, L. (2018) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2018.00326 · Cited by 149 · see citing works
Kim, Y.-K., Kim, O. Y., & Song, J. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.01270 · Cited by 109 · see citing works
Behavioral and structural adaptations to stress
Cameron, H. A., & Schoenfeld, T. J. (2018) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2018.02.002 · Cited by 105 · see citing works
Mild Prenatal Stress Causes Emotional and Brain Structural Modifications in Rats of Both Sexes
Soares‐Cunha, C., Coimbra, B., Borges, S., Domingues, A. V., Silva, D., Sousa, N., & Rodrigues, A. J. (2018) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2018.00129 · Cited by 86 · see citing works
Self-citationA thalamic-primary auditory cortex circuit mediates resilience to stress
Li, H.-Y., Zhu, M.-Z., Yuan, X.-R., Guo, Z.-X., Pan, Y.-D., Li, Y.-Q., & Zhu, X.-H. (2023) · Cell · doi:10.1016/j.cell.2023.02.036 · Cited by 64 · see citing works
Khan, A. R., Geiger, L., Wiborg, O., & Czéh, B. (2020) · Cells · doi:10.3390/cells9041026 · Cited by 62 · see citing works
Dioli, C., Patrício, P., Sousa, N., Kokras, N., Dalla, C., Guerreiro, S. R., Santos-Silva, M. A., Rego, A. C., Pinto, L., Ferreiro, E. B., et al. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0477-7 · Cited by 62 · see citing works
Self-citationZhong, F., Liu, L., Wei, J., Hu, Z., Li, L., Wang, S., Xu, J., Zhou, X., Li, C.-Q., Yang, Z., et al. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00776 · Cited by 61 · see citing works
Brymer, K. J., Fenton, E. Y., Kalynchuk, L., & Caruncho, H. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00121 · Cited by 49 · see citing works
Malberg, J. E., Hen, R., & Madsen, T. M. (2021) · Biological Psychiatry · doi:10.1016/j.biopsych.2021.01.010 · Cited by 46 · see citing works
Wu, Z., Xiao, L., Wang, H., & Wang, G. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.107653 · Cited by 46 · see citing works
Gaspar, R., Soares‐Cunha, C., Domingues, A. V., Coimbra, B., Baptista, F. I., Pinto, L., Ambrósio, A. F., Rodrigues, A. J., & Gomes, C. A. (2021) · Neurobiology of Stress · doi:10.1016/j.ynstr.2021.100302 · Cited by 41 · see citing works
Self-citationAlves, N. D., Patrício, P., Correia, J. S., Mateus‐Pinheiro, A., Machado-Santos, A. R., Loureiro‐Campos, E., Morais, M., Bessa, J. M., Sousa, N., & Pinto, L. (2017) · Brain Structure and Function · doi:10.1007/s00429-017-1490-3 · Cited by 37 · see citing works
Self-citationJones, K. L., Zhou, M., & Jhaveri, D. J. (2022) · npj Science of Learning · doi:10.1038/s41539-022-00133-y · Cited by 32 · see citing works
Li, Y., Fan, C., Wang, C., Wang, L., Yi, Y., Mao, X., Chen, X., Lan, T., Wang, W., & Yu, S. Y. (2022) · Science Advances · doi:10.1126/sciadv.add7063 · Cited by 27 · see citing works
Brivio, P., Sbrini, G., Corsini, G., Paladini, M. S., Racagni, G., Molteni, R., & Calabrese, F. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176261 · Cited by 29 · see citing works
Miguel, Z. D., Haditsch, U., Palmer, T. D., Azpiroz, A., & Sapolsky, R. M. (2018) · Molecular Psychiatry · doi:10.1038/s41380-017-0013-1 · Cited by 28 · see citing works
Gaspar, R., Soares‐Cunha, C., Domingues, A. V., Coimbra, B., Baptista, F. I., Pinto, L., Ambrósio, A. F., Rodrigues, A. J., & Gomes, C. A. (2022) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2022.834821 · Cited by 30 · see citing works
Self-citationLiu, X., Yuan, J., Guang, Y., Wang, X., & Feng, Z. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00613 · Cited by 25 · see citing works
Astrocytic plasticity at the dorsal dentate gyrus on an animal model of recurrent depression
Machado-Santos, A. R., Alves, N. D., Araújo, B., Correia, J. S., Patrício, P., Mateus‐Pinheiro, A., Loureiro‐Campos, E., Bessa, J. M., Sousa, N., & Pinto, L. (2019) · Neuroscience · doi:10.1016/j.neuroscience.2019.10.032 · Cited by 22 · see citing works
Self-citationMachado-Santos, A. R., Loureiro‐Campos, E., Patrício, P., Araújo, B., Alves, N. D., Mateus‐Pinheiro, A., Correia, J. S., Morais, M., Bessa, J. M., Sousa, N., et al. (2022) · Cells · doi:10.3390/cells11030390 · Cited by 22 · see citing works
Self-citationMateus‐Pinheiro, A., Patrício, P., Alves, N. D., Martins‐Macedo, J., Caetano, I., Silveira‐Rosa, T., Araújo, B., Mateus‐Pinheiro, M., Silva‐Correia, J., Sardinha, V. M., et al. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01287-8 · Cited by 21 · see citing works
Self-citationBrain circuitry underlying the ABC model of anxiety.
Bystritsky, A., Spivak, N., Dang, B. H., Becerra, S., Distler, M. G., Jordan, S., & Kuhn, T. (2021) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2021.03.030 · Cited by 12 · see citing works
Dutcher, E. G., López‐Cruz, L., Pama, E. A. C., Lynall, M.-E., Bevers, I. C. R., Jones, J. A., Khan, S. A., Sawiak, S. J., Milton, A. L., Clatworthy, M. R., et al. (2023) · Translational Psychiatry · doi:10.1038/s41398-023-02385-7 · Cited by 21 · see citing works
Home-cage behavior is impacted by stress exposure in rats
Eraslan, E., Castelhano-Carlos, M. J., Amorim, L., Soares‐Cunha, C., Rodrigues, A. J., & Sousa, N. (2023) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2023.1195011 · Cited by 17 · see citing works
Self-citationWolf, G., Lifschytz, T., Ben-Ari, H., Tatarskyy, P., Kreisel, T., Lotan, A., & Lerer, B. (2018) · Translational Psychiatry · doi:10.1038/s41398-018-0171-1 · Cited by 17 · see citing works
From energy metabolism to mood regulation: The rise of lactate as a therapeutic target
Zhang, S., Xia, J., He, W., Zou, Y., Liu, W., Li, L., Huang, Z., Li, Q., Li, Q. X., & Liu, W. (2025) · Journal of Advanced Research · doi:10.1016/j.jare.2025.04.018 · Cited by 20 · see citing works
Early life adversity across different cell- types in the brain
Warhaftig, G., Almeida, D. M., & Turecki, G. (2023) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2023.105113 · Cited by 16 · see citing works
Potential role of gut microbiota in major depressive disorder: A review
Khaledi, M., Sameni, F., Gholipour, A., Shahrjerdi, S., Golmohammadi, R., Ghaleh, H. E. G., Poureslamfar, B., Hemmati, J., Mobarezpour, N., Milasi, Y. E., et al. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e33157 · Cited by 17 · see citing works
Kafetzopoulos, V., Kokras, N., Sousa, N., Antoniou, K., Sotiropoulos, I., & Dalla, C. (2020) · Neuroscience · doi:10.1016/j.neuroscience.2020.08.017 · Cited by 14 · see citing works
Self-citationRodent models of stress and dendritic plasticity – Implications for psychopathology
Laine, M. A., & Shansky, R. M. (2022) · Neurobiology of Stress · doi:10.1016/j.ynstr.2022.100438 · Cited by 14 · see citing works
Guimarães, M. R., Anjo, S. I., Cunha, A. M., Esteves, M., Sousa, N., Almeida, A., Manadas, B. J., & Leite‐Almeida, H. (2021) · Pain · doi:10.1097/j.pain.0000000000002192 · Cited by 13 · see citing works
Self-citationBrivio, P., Gallo, M. T., Gruca, P., Łasoń, M., Litwa, E., Fumagalli, F., Papp, M., & Calabrese, F. (2022) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-022-01470-0 · Cited by 13 · see citing works
Research on Xiaoyao Powder in the treatment of depression based on epigenetics and quality markers
Wang, J., Wu, Q., Ou, C., Lu, G., & Yu, H. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1223451 · Cited by 12 · see citing works
Huang, S., Nie, Y., Qin, J., Wen, M., Wang, Q., Xie, F., Song, F., & Yang, B. (2024) · Scientific Reports · doi:10.1038/s41598-024-79558-x · Cited by 11 · see citing works
Martins‐Macedo, J., Salgado, A. J., Gomes, E. D., & Pinto, L. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.09.030 · Cited by 11 · see citing works
Self-citationLarivee, R., Johnson, N., Freedgood, N. R., Cameron, H. A., & Schoenfeld, T. J. (2022) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2022.940125 · Cited by 12 · see citing works
Zhang, Y., Zhang, X., Liu, N., Ren, S., Xia, C., Yang, X., Lou, Y., Wang, H., Zhang, N., Xu, Y., et al. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.675430 · Cited by 11 · see citing works
Xu, G., Yuan, M., He, H., Jin, Y., Li, X., Yan, H., Liu, G., Wu, Z., Zhang, X., Chen, Y., et al. (2025) · Molecular Psychiatry · doi:10.1038/s41380-025-03344-y · Cited by 10 · see citing works
Spero, V., Paladini, M. S., Brivio, P., Riva, M. A., Calabrese, F., & Molteni, R. (2022) · Psychopharmacology · doi:10.1007/s00213-022-06140-6 · Cited by 10 · see citing works
Li, X., Sun, X., Sun, J., Zu, Y., Zhao, S., Sun, X., Li, L., Zhang, X., Wang, W., Liang, Y., et al. (2020) · Behavioural Brain Research · doi:10.1016/j.bbr.2020.112618 · Cited by 10 · see citing works
The development and tendency of depression researches: Viewed from the microbiota-gut-brain axis
Liang, S., Wu, X., Xu, H., Niu, Y., & Jin, F. (2018) · Chinese Science Bulletin (Chinese Version) · doi:10.1360/n972017-01182 · Cited by 8 · see citing works
Kajimoto, K., Hisada, C., Ochi, S., Yoshikawa, E., Suzuki, A., Tsugane, H., Zhang, J.-H., Iinuma, M., Kubo, K., & Azuma, K. (2021) · Archives of Oral Biology · doi:10.1016/j.archoralbio.2021.105245 · Cited by 9 · see citing works
Waters, R. C., Worth, H. M., Vasquez, B., & Gould, E. (2022) · Neurobiology of Stress · doi:10.1016/j.ynstr.2022.100436 · Cited by 8 · see citing works
Wu, Z., Wang, G., Wang, H., Xiao, L., Wei, Y., & Yang, C. (2020) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2020.02.007 · Cited by 8 · see citing works
Patrício, P., Mateus‐Pinheiro, A., Machado-Santos, A. R., Alves, N. D., Correia, J. S., Morais, M., Bessa, J. M., Rodrigues, A. J., Sousa, N., & Pinto, L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111798 · Cited by 7 · see citing works
Self-citationMartins-Macedo, J., Araújo, B., Anjo, S. I., Silveira-Rosa, T., Patrício, P., Alves, N. D., Silva, J. M., Teixeira, F. G., Manadas, B., Rodrigues, A. J., et al. (2024) · Molecular Psychiatry · doi:10.1038/s41380-024-02490-z · Cited by 6 · see citing works
Self-citationMatar, D., Serhan, A., Bilani, S. E., Faraj, R. A., Hadi, B. A., & Fakhoury, M. (2024) · Advances in experimental medicine and biology · doi:10.1007/978-981-97-4402-2_2 · Cited by 7 · see citing works
Vega‐Rivera, N. M., González-Trujano, M. E., Luna‐Angulo, A. B., Sánchez‐Chapul, L., & Estrada-Camarena, E. M. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1211663 · Cited by 7 · see citing works
Hofstra, B., Kas, M. J., & Verbeek, D. S. (2024) · Translational Psychiatry · doi:10.1038/s41398-024-02968-y · Cited by 6 · see citing works
Factors Regulating Neurogenesis in the Adult Dentate Gyrus
Zhang, L., & Zhang, X.-H. (2018) · Hippocampus · doi:10.5772/intechopen.75631 · Cited by 4 · see citing works
Loureiro‐Campos, E., Mateus-Pinheiro, A., Patrício, P., Soares‐Cunha, C., Silva, J., Sardinha, V. M., Mendes-Pinheiro, B., Silveira‐Rosa, T., Domingues, A. V., Rodrigues, A. J., et al. (2021) · eLife · doi:10.7554/elife.70685 · Cited by 5 · see citing works
Self-citationThe neural mechanism underlying resilience
Liu, H., Zhang, C., & Yang, L. (2019) · Advances in Psychological Science · doi:10.3724/sp.j.1042.2019.00312 · Cited by 5 · see citing works
Ribeiro, I., Silveira‐Rosa, T., Martins‐Macedo, J., Marques-Ferraz, L., Dourado, A. R., Martins-Ferreira, G., Farrugia, F., Rodrigues, A. J., Abrous, D. N., Alves, N. D., et al. (2025) · Neurobiology of Stress · doi:10.1016/j.ynstr.2025.100743 · Cited by 3 · see citing works
Self-citationIdentification of the antidepressive properties of C1, a specific inhibitor of Skp2, in mice
Li, F., Huang, C., Lu, X., Xiang, H., Wang, D., Chen, Z., Chen, J., He, H., & Yuan, X. (2021) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000604 · Cited by 3 · see citing works
EGFR, NF-κB and noncoding RNAs in precision medicine
Li, Y., Liu, X., & Ma, Z. (2022) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2022.05.001 · Cited by 3 · see citing works
Fluoxetine Can Cause Epileptogenesis and Aberrant Neurogenesis in Male Wild-Type Mice
Musaelyan, K., Horowitz, M. A., McHugh, S. B., & Szele, F. G. (2023) · Developmental Neuroscience · doi:10.1159/000531478 · Cited by 3 · see citing works
Distinct behavioural and neurovascular signatures induced by acute and chronic stress in rats
Simões, D. M., Carreira, J., Henriques, A., Gaspar, R., Sanches, E. S., Baptista, F. I., & Silva, A. P. (2025) · Behavioural Brain Research · doi:10.1016/j.bbr.2025.115706 · Cited by 3 · see citing works
Lin, Y., Chen, K. C., Yang, Y. K., & Hsiao, Y. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02336-7 · Cited by 3 · see citing works
Robert, C., da Silva, F. D., Fabiola, S., Martinelli, C., Farrugia, F., Sturaro, C., Pacary, E., Rampon, C., Ruzza, C., & Moulédous, L. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05062-6 · Cited by 2 · see citing works
Laham, B. J., & Gould, E. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819641-0.00015-3 · Cited by 2 · see citing works
Kaplan, J., Somohano, V. C., Eddy, A., Oken, B., & Wahbeh, H. (2022) · Journal of Loss and Trauma · doi:10.1080/15325024.2022.2030019 · Cited by 1 · see citing works
Triggers of transient global amnesia and recurrence: A retrospective analysis
Gandelman‐Marton, R., & Theitler, J. (2025) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2025.123583 · Cited by 1 · see citing works
Metabolic stress-response in female rats: β-oxidation-induced vulnerability vs adaptive resilience
Brivio, P., Pedretti, S., Gallo, M. T., Palumbo, A., Boccazzi, M., Gruca, P., Łasoń, M., Litwa, E., Biała, D., Fumagalli, F., et al. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118747 · Cited by 1 · see citing works
Stress-Induced Hippocampal Volume Loss Is Adult Neurogenesis Independent
Murthy, S. S. (2017) · Biological Psychiatry · doi:10.1016/j.biopsych.2017.10.013 · Cited by 1 · see citing works
Elek, Z. (2020) · International Journal of Cognition and Behaviour · doi:10.23937/2690-3172/1710006 · Cited by 1 · see citing works
Peng, Q., Kong, Y., Shi, L., Yan, Y. C., Yao, Y., Wen, Y., Liang, Y.-M., Lai, C., Deng, Z., & Yan, H. (2020) · Neuroscience Letters · doi:10.1016/j.neulet.2020.135361
Wu, Z., Wang, G., Wang, H., Xiao, L., Wei, Y., & Yang, C. (2019) · Research Square · doi:10.21203/rs.2.13724/v1
Léglise, M. (1992) · Nature et progrès
Verbeek, D. S., Hofstra, B., & Kas, M. J. (2023) · Research Square · doi:10.21203/rs.3.rs-2556408/v1
Iwai, T., Mishima, R., Hirayama, S., Nakajima, H., Oyama, M., Watanabe, S., Fujii, H., & Tanabe, M. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13020608
Traces of Parenthood but Not Pregnancy Loss in UK Biobank Structural Brain MRI Data
Fischer, J. L., Skalkidou, A., Derntl, B., & Kaufmann, T. (2026) · Human Brain Mapping · doi:10.1002/hbm.70527
Tudosie, A. C., Marin, L.-M., Popa, S. G., & Golli, A. L. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27083628 · Cited by 1 · see citing works
- Authors
- Alves, N. D., Correia, J. S., Patrício, P., Mateus-Pinheiro, A., Machado-Santos, A. R., Loureiro-Campos, E., Morais, M., Bessa, J. M., Sousa, N., & Pinto, L.
- Affiliations
- University of Minho (PT)
- Corresponding author
- Pinto, L
- Venue
- Translational Psychiatry
- Published
- 2017-03-14
- Volume
- 7
- Issue
- 3
- Pages
- e1058-e1058
- ISSN
- 2158-3188 (ISSN-L)
- PMC
- PMC5416672
- OpenAlex
- W2614795543
- Semantic Scholar
- b3ac803527d9fdb61d7c9cb2286512e891dd682a
- Cited by
- 79
- References
- 47
- Citations by year
- 2026: 2 · 2025: 7 · 2024: 6 · 2023: 8 · 2022: 11 · 2021: 15 · 2020: 9 · 2019: 7 · 2018: 11 · 2017: 2
- FWCI
- 3.36
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Translational Psychiatry (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) (submittedVersion, other-oa)
- Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) (submittedVersion, cc-by-nc-nd)
- Funders
- Fundação para a Ciência e a Tecnologia (IF/01079/2014, 01-0145, COMPETE, POCI-01-0145, NORTE-01–0145-FEDER-000013, PORTUGAL 2020, POCI‐01‐0145‐FEDER‐007038, POCI-01-0145-FEDER-, NORTE2020, POCI-01-, NORTE-01-0145)
- European Regional Development Fund (COMPETE, POCI-01, 01-0145-FEDER-000013, 01-0145, NORTE-01-0145-FEDER-000013, POCI-01-0145, POCI-01-0145-FEDER-007038, POCI-01-0145- FEDER, NORTE-2020)
- Topics
- Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
- Health Sciences › Medicine › Pharmacology › Treatment of Major Depression
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Keywords
- recurrent depression, adult hippocampal neurogenesis, neuroplasticity, chronic mild stress, fluoxetine, imipramine, antidepressant response, behavioral resilience, dendritic atrophy, granule neurons, cell proliferation, emotional deficits, cognitive impairment
- MeSH terms
- Animals, Antidepressive Agents, Behavior, Animal, Depressive Disorder, Disease Models, Animal, Disease Susceptibility, Fluoxetine, Hippocampus, Imipramine, Male, Neuronal Plasticity, Recurrence, Stress, Psychological, Rats, Wistar, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-09.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-09.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review